Dercum’s Disease Market Global KEY Players, Segmental Overview, Regional Growth and Forecast till 2023
Market Research Future (MRFR) publishes periodic market
research reports “Dercum’s Disease Market Research Report – Forecast to 2023”
Market Summary:
Global Dercum’s Disease Research Report: by Treatment
(Surgery, Medication, Liposuction, Electrotherapy, Acupuncture, Others), by
Distribution Channel (Hospital Pharmacies, Retail Pharmacies), by End-User
(Hospital & Clinics, Others)– Forecast Till 2023
The global dercum’s disease market
is anticipated to be growing due to factors such increasing expenditures in the
healthcare sector in the developed as well as developing economies, growing
occurrences of lipomas, increasing prevalence of rare diseases, and rising
research and development activities. On the other hand, lack of awareness about
the disease is likely to hamper the growth of the market over the forecast
period.
Dercum’s disease is a rare pain syndrome characterized by
chronically painful growths of fatty tissue or lipomas. These lipomas most
commonly occur in the upper arms, upper legs, and trunk region. According to a
report by the American Society of Interventional Pain Physicians in 2017,
although women are most commonly affected by this condition, about 16% of the
reported cases were in men. The common symptoms of this condition include
painful fatty lipomas covering the body, obesity majorly in women in menopausal
age, weakness, memory issues, elevated heart rate, joint aches, depression, and
dementia. Currently, there is no cure for this condition and it is treated
symptomatically with surgery, alternative therapies, and with medications such
as non-steroidal anti-inflammatory drugs, diuretics, among others.
Key Players of the market
·
Pfizer, Inc.,
·
Abbvie, Inc.,
·
Johnson & Johnson,
·
GlaxoSmithKline Plc,
·
Merck & Co., Inc.,
·
Novartis,
·
F. Hoffman,
·
La Roche AG, Eli Lily and Company,
·
AstraZeneca PLC,
·
Amgen,
·
Valeant Pharmaceuticals,
·
Syneron Medical,
·
St. Jude Medical Inc.
·
Alimed, Inc
Global Dercum’s Disease Research Report: by Treatment
(Surgery, Medication, Liposuction, Electrotherapy, Acupuncture, Others), by
Distribution Channel (Hospital Pharmacies, Retail Pharmacies), by End-User
(Hospital & Clinics, Others)– Forecast Till 2023.To know more visit https://www.marketresearchfuture.com/reports/dercums-disease-market-6350
On the regional basis, the dercum’s disease market in the
Americas is segmented into two major regions, i.e., North America and South
America. The North American region is likely to hold the major share in the
global dercum’s disease market, owing to the owing to the presence of a
well-established healthcare segment, and increasing disposable income.
Moreover, increasing funding for research and development by government fuels
the market growth in this region.
Intended Audience
·
Pharmaceutical Companies
·
Research and Development (R&D) Companies
·
Diagnostic Laboratories
·
Government Research Institute
·
Academic Institutes and Universities
Browse Other Related healthcare report
Blood
Glucose Monitoring Market Research Report - Global Forecast till 2023
Surgical
Lights Market Research Report - Forecast to 2023
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to
unravel the complexity of various industries through our Cooked Research Report
(CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R),
Continuous-Feed Research (CFR), and Market Research & Consulting Services.
In order to stay updated with technology and work process of
the industry, MRFR often plans & conducts meet with the industry experts
and industrial visits for its research analyst members.
Contact
Comments
Post a Comment